↓ Skip to main content

Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma

Overview of attention for article published in Frontiers in oncology, June 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter
6 X users

Citations

dimensions_citation
27 Dimensions

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
Published in
Frontiers in oncology, June 2019
DOI 10.3389/fonc.2019.00449
Pubmed ID
Authors

Qiumei Yao, Yinlei Bai, Alberto Orfao, Chor Sang Chim

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 6 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 10 37%
Researcher 3 11%
Student > Ph. D. Student 3 11%
Student > Bachelor 2 7%
Other 1 4%
Other 4 15%
Unknown 4 15%
Readers by discipline Count As %
Unspecified 10 37%
Biochemistry, Genetics and Molecular Biology 5 19%
Medicine and Dentistry 3 11%
Agricultural and Biological Sciences 2 7%
Energy 1 4%
Other 1 4%
Unknown 5 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 July 2019.
All research outputs
#15,159,670
of 25,746,891 outputs
Outputs from Frontiers in oncology
#4,237
of 22,775 outputs
Outputs of similar age
#186,582
of 368,121 outputs
Outputs of similar age from Frontiers in oncology
#94
of 289 outputs
Altmetric has tracked 25,746,891 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 22,775 research outputs from this source. They receive a mean Attention Score of 3.1. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,121 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 48th percentile – i.e., 48% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 289 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 67% of its contemporaries.